All In MedTech

FDA Clearance Tracker · P840001-S071

ITREL (R) TOTALLY IMPLANTABLE

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 17, 2003 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 17, 2003

Approved

Time to decision

84 days

Received Aug 25, 2003. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P840001-S071
Device name
ITREL (R) TOTALLY IMPLANTABLE
Applicant location
Minneapolis, MN
Received
Aug 25, 2003
Decided
Nov 17, 2003
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P840001

Device type

Device class
Class III

Every decision under product code LGW

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT MEDTRONIC PUERTO RICO OPERATIONS COMPANY (MPROC) MEDREL, JUNCOS, PUERTO RICO.

Source documents

Other decisions for Medtronic Neuromodulation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.